Schizophrenia
Treatment Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016
Future Market Insights
www.futuremarketinsights.com
[email protected]
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research Capabilities
Sector Coverage








Customized Research
Syndicated Research
Investment Research
Social Media Research
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
Customized
Research
Subscription Information
Syndicated
Research
For detailed subscription information please contact
Investment
Research
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Social Media
Research
Hari. T (Sr. Manager - Global Business Development)
Email: [email protected]




Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Report
Description
Report Description
Schizophrenia is a chronic mental disorder, characterized by poor emotional responses,
breakdown of thinking and lack of social and physical motivation. The prominent causes
of the disease include genetic malignancies, neuro-trauma, shocking incidence in life,
drug and alcohol abuse and many others. Schizophrenia is a serious disorder which
affects how a person thinks, feels and acts. Successful treatment for schizophrenia aims
to relieve current symptoms, prevent future psychotic episodes and restore one’s ability
to function and enjoy a meaningful life. The signs of schizophrenia are different for
everyone. Symptoms may develop slowly over months or years, or may appear very
abruptly. The disease may come and go in relapse and remission. Hence, recovery from
schizophrenia is a lifelong process.
SchizophreniaTreatment Market: Drivers and Restraints
The schizophrenia treatment market is primarily driven by increased prevalence of
schizophrenic disorders due to change in lifestyle, extensive R&D, increase in incidence of
various addictions such as alcohol, narcotics and others. Demand of sophisticated
therapy by physicians and patients is also driving the schizophrenic treatment market to a
great extent. On the contrary, huge cost of R&D and therapy, lack of medical
infrastructure, and lack of awareness in certain regions of the world are some of the
hurdles that are expected to restrict the growth of this market.
Request free sample Report: http://www.futuremarketinsights.com/reports/sample/repgb-1329
Report
Description
Report Description
Schizophrenia Treatment Market: Segmentation
Schizophrenia treatment market is segmented on the basis of product type, distribution
channel and geography.
Based on product type, schizophrenia treatment market is segmented as follows:
•Medications
• Conventional or typical antipsychotic drugs
• Atypical antipsychotic drugs
•Therapies
Based on distribution channel, schizophrenia treatment market is segmented as follows:
•Hospitals including hospital pharmacies
•Clinics
•Retail pharmacies
•Rehabilitation Centers
Schizophrenia Treatment Market: Overview
According to WHO, there are around 24 million people suffering from either
schizophrenia or similar symptoms.
Report
Description
Report Description
Moreover, due to strong R&D activities, newer drugs and treatments are being
introduced in the market, such as ziprasidone hydrochloride. Medications are the
cornerstone for the treatment of schizophrenia. However, medications may lead to side
effects. Hence, medication with supportive services and therapies is a perfect
combination to treat schizophrenia. Relationship problems, risk of attempting suicide,
alcohol and drug abuse and consequently, disruption to normal daily activities has led to
the growth of schizophrenia treatment market.
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1329
SchizophreniaTreatment Market: Region-wise Outlook
The schizophrenia treatment market is also segmented on the basis of geography, such as
North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan,
Middle East and Africa. The North American region is considered as the largest market,
followed by Europe. However, Asia-Pacific region is considered as the most promising
market in the upcoming future.
SchizophreniaTreatment Market: Key Players
Some of the top key players in schizophrenia treatment market include Novartis AG,
AbbVie, Inc., PsychoGenics, Inc., Pfizer, Inc., Eli-Lilly and Company, Bristol-Myers Squibb
Company, AstraZeneca Plc., Avineuro Pharmaceuticals, Inc. and Merz Pharmaceuticals
GmbH.
Browse full report: http://www.futuremarketinsights.com/reports/schizophrenia-
Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact: Mr. Sudip Saha
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705